Dermocosmetics 2026: How Pharmacy Brands Rebuild Their Range
European pharmacy brands are rebuilding around evidenced actives. Here is the claim-to-evidence-to-channel loop, and how stability testing drives MOQ.
Distributor Private Label: The Pivot Nobody Warns You About
A regional distributor lost resale margin to online retail, so it launched its own label. The real costs were inventory, compliance and channel conflict.
Drugstore Own Label: What Sells on European Pharmacy Shelves
Own-label share keeps rising across European drugstore shelves. The margin structure, localisation rules and compliance spend that come first.
Halal Skincare: What GCC and Indonesian Buyers Check First
Halal, vegan and cruelty-free are three parallel tracks into Gulf and Indonesian shelves. Here is what each buyer checks first, and why halal raises MOQ.
Private Label on a 500-Unit MOQ: A 3-Person Team's Launch
A three-person team built a 24-SKU skincare range on a 500-unit MOQ. Here is the budget and trade-offs behind a low-MOQ private-label launch in 2026.
Glossier Case Study: Building a Cult Beauty Brand Through Community (2026 Update)
How Emily Weiss built Glossier from a blog (Into The Gloss) into a cult DTC beauty brand valued at $1.8B. Community-first strategy, product development insights, and lessons for private label brands.
How The Ordinary Changed Beauty: Lessons for Private Label Brands in 2026
Case study: How DECIEM built The Ordinary into a $2B+ brand with radical ingredient transparency, $5–$10 price points, and a direct-to-consumer model. Key lessons for emerging OEM/private label brands
No articles match your filters.
What Winning Beauty Brands Did in 2026
The brands in our case library scaled on transparency, community and disciplined supply chains — not big budgets. Each story below is a repeatable playbook for a new brand.
~$1.8B
Glossier peak value
~$1B
DECIEM/The Ordinary exit
DTC
Default channel
Community
The real moat
- Lead with 1-3 hero SKUs validated by your community, not a 20-SKU catalogue.
- Radical transparency (the active + the price) builds trust that compounds.
- Keep the supply chain agile so feedback reaches the lab in weeks, not quarters.